Fayez Sarofim & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
4,323
-80
| -2% | -$32.4K | ﹤0.01% | 164 |
|
|
2025
Q1 | $2.19M | Sell |
4,403
-239
| -5% | -$119K | 0.01% | 147 |
|
|
2024
Q4 | $2.41M | Sell |
4,642
-106
| -2% | -$55.1K | 0.01% | 148 |
|
|
2024
Q3 | $2.94M | Buy |
4,748
+1,190
| +33% | +$736K | 0.01% | 134 |
|
|
2024
Q2 | $1.97M | Buy |
3,558
+156
| +5% | +$86.3K | 0.01% | 146 |
|
|
2024
Q1 | $1.98M | Sell |
3,402
-424
| -11% | -$246K | 0.01% | 143 |
|
|
2023
Q4 | $2.11M | Buy |
3,826
+184
| +5% | +$101K | 0.01% | 137 |
|
|
2023
Q3 | $1.84M | Sell |
3,642
-105
| -3% | -$53.1K | 0.01% | 145 |
|
|
2023
Q2 | $1.95M | Buy |
3,747
+66
| +2% | +$34.4K | 0.01% | 139 |
|
|
2023
Q1 | $2.12M | Sell |
3,681
-37
| -1% | -$21.3K | 0.01% | 142 |
|
|
2022
Q4 | $2.05M | Hold |
3,718
| – | – | 0.01% | 140 |
|
|
2022
Q3 | $1.89M | Buy |
3,718
+1,378
| +59% | +$699K | 0.01% | 140 |
|
|
2022
Q2 | $1.27M | Buy |
2,340
+461
| +25% | +$250K | ﹤0.01% | 172 |
|
|
2022
Q1 | $1.11M | Buy |
1,879
+97
| +5% | +$57.3K | ﹤0.01% | 188 |
|
|
2021
Q4 | $1.19M | Buy |
1,782
+223
| +14% | +$149K | ﹤0.01% | 195 |
|
|
2021
Q3 | $891K | Sell |
1,559
-813
| -34% | -$465K | ﹤0.01% | 202 |
|
|
2021
Q2 | $1.2M | Buy |
2,372
+813
| +52% | +$410K | ﹤0.01% | 187 |
|
|
2021
Q1 | $711K | Buy |
1,559
+27
| +2% | +$12.3K | ﹤0.01% | 200 |
|
|
2020
Q4 | $714K | Buy |
1,532
+150
| +11% | +$69.9K | ﹤0.01% | 191 |
|
|
2020
Q3 | $610K | Hold |
1,382
| – | – | ﹤0.01% | 184 |
|
|
2020
Q2 | $501K | Buy |
1,382
+400
| +41% | +$145K | ﹤0.01% | 192 |
|
|
2020
Q1 | $278K | Buy |
+982
| New | +$278K | ﹤0.01% | 207 |
|